Cefaclor 즉시형 과민반응을 나타낸 환자들의 임상적 및 면역학적 특징
Clinical and Immunologic Evaluations of Immediate Hypersensitivity to Cefaclor
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Cefaclor is commonly prescribed for various infectious diseases. It is known as a major causative antibiotic that induces drug hypersensitivity reactions. The aim of this study is to evaluate clinical and immunologic features of cefaclor immediate hypersensitivity. Methods: We conducted a retrospective study on the patients with histories of immediate hypersensitivity to cefaclor at Ajou University Hospital between January 2002 and February 2011. Serum specific IgE to cefaclor was measured using the ImmunoCAP system. Results: Fifty patients were enrolled in this study. The most common immediate hypersensitivity reaction was anaphylaxis (38/50, 76%), followed by urticaria/angioedema (12/50,24%). High serum specific IgE to cefaclor was noted in 40patients (80%). There were no significant differences in clinical parameters whether the patients had serum specific IgE or not, except that serum total IgE level was higher in patients with high serum specific IgE to cefaclor (P=0.042). Serum specific IgE to penicillin was detected in 26.1% of the patients with high serum specific IgE to cefaclor, while serum specific IgE to aminopenicillin was not found in any of the study subjects. Conclusion: Immediate hypersensitivity to cefaclor occurred mostly through the IgE-mediated mechanism, and anaphylaxis was the most common manifestation. Cross reactivity with penicillin was noted in 26% of the patients, but no cross reactivity with aminopenicillin was noted.
Abstract
Background: Cefaclor is commonly prescribed for various infectious diseases. It is known as a major causative antibiotic that induces drug hypersensitivity reactions. The aim of this study is to evaluate clinical and immunologic features of cefaclor immediate hypersensitivity. Methods: We conducted a retrospective study on the patients with histories of immediate hypersensitivity to cefaclor at Ajou University Hospital between January 2002 and February 2011. Serum specific IgE to cefaclor was measured using the ImmunoCAP system. Results: Fifty patients were enrolled in this study. The most common immediate hypersensitivity reaction was anaphylaxis (38/50, 76%), followed by urticaria/angioedema (12/50,24%). High serum specific IgE to cefaclor was noted in 40patients (80%). There were no significant differences in clinical parameters whether the patients had serum specific IgE or not, except that serum total IgE level was higher in patients with high serum specific IgE to cefaclor (P=0.042). Serum specific IgE to penicillin was detected in 26.1% of the patients with high serum specific IgE to cefaclor, while serum specific IgE to aminopenicillin was not found in any of the study subjects. Conclusion: Immediate hypersensitivity to cefaclor occurred mostly through the IgE-mediated mechanism, and anaphylaxis was the most common manifestation. Cross reactivity with penicillin was noted in 26% of the patients, but no cross reactivity with aminopenicillin was noted.
참고문헌 (37)
- Demoly P, "Epidemiology of drug allergy", Curr Opin Allergy Clin Immunol, 1, pp.305~310 (2001)
- Grouhi M, "Anaphylactic reaction to oral cefaclor in a child", Pediatrics, 103, pp.e50~ (1999)
- Kelkar PS, "Cephalosporin allergy", N Engl J Med, 345, pp.804~809 (2001)
- King BA, "Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions", J Paediatr Child Health, 39, pp.677~681 (2003)
- Romano A, "Diagnosing immediate reactions to cephalosporins", Clin Exp Allergy, 35, pp.1234~1242 (2005)
- Novembre E, "Cefaclor anaphylaxis in children", Allergy, 64, pp.1233~1235 (2009)
- "Heterogeneity of the IgE response to allergenic determinants of cefaclor in serum samples from patients with cefaclor-induced anaphylaxis", ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 94, pp.700~704 (2005), AMER COLL ALLERGY ASTHMA IMMUNOLOGY
- Antúnez C, "Immediate hypersensitivity reactions to penicillins and other betalactams", Curr Pharm Des, 12, pp.3327~3333 (2006)
- Hama R, "High incidence of anaphylactic reactions to cefaclor", Lancet, 1, pp.1331~ (1988)
- Ben-Shoshan M, "Anaphylaxis: past, present and future", Allergy, 66, pp.1~14 (2011)
- Brown SG, "Clinical features and severity grading of anaphylaxis", J Allergy Clin Immunol, 114, pp.371~376 (2004)
- Norrby SR, "Side effects of cephalosporins", Drugs, 34(Suppl 2), pp.105~120 (1987)
- Bernardini R, "Long persistence of IgE antibody to cefaclor", Allergy, 55, pp.984~985 (2000)
- Pham NH, "Beta-Lactam drug allergens: fine structural recognition patterns of cephalosporin-reactive IgE antibodies", J Mol Recognit, 9, pp.287~296 (1996)
- 최정희, "Cefaclor에 의한 아나필락시스 환자에서 cefaclor 특이 IgE 항체 측정", 천식 및 알레르기, 23(2), pp.414~419 (2003), 대한천식알레르기학회
- 이원익, "아스피린 과민증 환자에게 발생한 세파클로에 의한 아나필락시스 1예", 천식 및 알레르기, 26(3), pp.239~241 (2006), 대한천식알레르기학회
- Kim SH, "A case of anaphylactic reaction to oral cefaclor", Korean J Med, 65(Suppl 3), pp.S882~S884 (2003)
- 변진수, "세파클로에 의한 아나필락시스 1예", 천식 및 알레르기, 28(3), pp.231~323 (2008), 대한천식알레르기학회
- Murray DL, "Cefaclor--a cluster of adverse reactions", N Engl J Med, 303, pp.1003~ (1980)
- Kammer RB, "Cefaclor in management of streptococcal pharyngitis, otitis media, and skin infections", Ann Otol Rhinol Laryngol Suppl, 90(3 Pt 3), pp.79~81 (1981)
- Beghetti M, "Hypersensitivity myocarditis caused by an allergic reaction to cefaclor", J Pediatr, 132, pp.172~173 (1998)
- Romano A, "Diagnosing hypersensitivity reactions to cephalosporins in children", Pediatrics, 122, pp.521~527 (2008)
- Matasar MJ, "Epidemiology of anaphylaxis in the United States", Curr Allergy Asthma Rep, 3, pp.30~35 (2003)
- Liberman P, "Anaphylaxis, In Middleton's allergy: principles & practice. 7th ed", pp.2009, Mosby
- 김무정, "수원의 한 대학병원에서 10년간 경험한 아나필락시스 환자 분석", 천식 및 알레르기, 28(4), pp.298~304 (2008), 대한천식알레르기학회
- 최정희, "단일 3차 의료기관에서 약물 이상 반응의 빈도", 대한내과학회지, 67(3), pp.290~296 (2004), 대한내과학회
- 김민강, "단일기관에서 전산을 통해 수집된 자발적 약물유해반응 보고사례들의 분석", 대한내과학회지, 77(5), pp.601~609 (2009), 대한내과학회
- Leone R, "Drug-related deaths: an analysis of the Italian spontaneous reporting database", Drug Saf, 31, pp.703~713 (2008)
- Doña I, "Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response", Clin Exp Allergy, 41, pp.86~95 (2011)
- Celik G, "Drug allergy, In Middleton's allergy: principles & practice. 7th ed", pp.2009, Mosby
- Bernard Yu-Hor Thong, "Update on the Management of Antibiotic Allergy", Allergy, Asthma & Immunology Research, 2(2), pp.77~86 (2010), 대한천식알레르기학회
- Co Minh HB, "Systemic reactions during skin tests with beta-lactams: a risk factor analysis", J Allergy Clin Immunol, 117, pp.466~468 (2006)
- Madaan A, "Cephalosporin allergy", Immunol Allergy Clin North Am, 24, pp.463~476 (2004)
- Blanca M, "Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy", Allergy, 56, pp.862~870 (2001)
- Kelkar PS, "Cephalosporin allergy", N Engl J Med, 345, pp.804~809 (2001)
- Sánchez-Sancho F, "Synthesis, characterization and immunochemical evaluation of cephalosporin antigenic determinants", J Mol Recognit, 16, pp.148~156 (2003)
- Antunez C, "Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins", J Allergy Clin Immunol, 117, pp.404~410 (2006)